Chromocell Therapeutics C...

2.68
-0.02 (-0.74%)
At close: Jan 23, 2025, 3:59 PM
2.86
6.70%
After-hours Jan 23, 2025, 07:38 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20
Net Income -7.38M -2.46M -595.39K -660.58K
Depreciation & Amortization 188.12K n/a n/a n/a
Stock-Based Compensation 3.96M 110.15K n/a n/a
Other Working Capital 424.07K 227.26K 71.87K n/a
Other Non-Cash Items 201.60K -163.03K 585.91K 2.97M
Deferred Income Tax n/a n/a n/a n/a
Change in Working Capital 2.05M 640.86K -755.83K -2.97M
Operating Cash Flow -981.03K -1.57M -1.59M -3.63M
Capital Expenditures 1.00 n/a n/a n/a
Acquisitions n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a
Investing Cash Flow n/a n/a n/a n/a
Debt Repayment 766.94K 400.00K n/a 241.79K
Common Stock Repurchased n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a
Other Financial Acitivies n/a 1.22M 1.59M 3.38M
Financial Cash Flow 1.02M 1.62M 1.59M 3.63M
Net Cash Flow 41.32K 55.07K n/a n/a
Free Cash Flow -981.03K -1.57M -1.59M -3.63M